67 Comments
 

Would disagree they advised on Translates sale to Sanofi, Arena to Pfizer, and Jazz on its acquisition of GW. I'd say they've done pretty well the past couple of years especially this year given biopharma M&A has been slow.

 

CVP has been on practically every single biotech deal over the past 2 years I believe 

 
[Comment removed by mod team]
 
[Comment removed by mod team]
 
[Comment removed by mod team]
 

HL’s healthcare group did the most M&A deals in the US for 2020. Not sure where they stand for 2021 but I’d imagine they’re at the top again or close to it.

 

Centerview has consistently been at the top especially in big pharma and biotech, it's honestly very impressive and not much of a debate 

 
[Comment removed by mod team]
 

As others have mentioned, CVP is the qatalyst of healthcare deals/ independent advisor that is the gold standard for large deals in the vertical. Such a large industry however, there can be many winners at different size of deals. I’m sure one of WB, HL, Laz, or Jeff have a pretty dominant healthcare practice/ own deals in a smaller range are alternate vertical. 

Worth keeping in mind, some banks might have an exceptional biotech MD, but a poor med-tech practice, so likely numerous winners given how large the space is.

 

True but they do quite unique deal structures and have had some solid exits to PE (few Veritas exits in recent year and a Bain Cap) and healthcare corp exits (Roivant exits were very interesting, far from vanilla corp exits IMO - seems like everyone who exited had a lot of say/wore multiple hats). 

I believe they pay street or slightly above (one of the WSO datapoints state an ASO1 made 350K in 2019 but that may be an exception since they were on 4 billion dollar deals that year which is definitely not the norm for them).

 

TT: great place to be for HCIT. Unsure about solid exits/laterals honestly.

Cain: decent MM/LMM placement in HC PE. Strong laterals. For associates and above: I've seen Citi, William Blair. One of the VP/Directors moved over to McK as an associate partner. For analysts: JPM, PWP, Dyal & Co. Cain Bros seems to have had a turnover issue since they got acquired by KeyBanc but are just a slight notch below Jeff/HL who were tied for #1 this year for MM healthcare deals under $1B (Cain is at 20 vs. Jeff/HL - 22).

 

Quia et culpa ut est mollitia dicta. Iure magnam aut sunt ad qui. Nostrum deserunt unde dicta odio atque fugit cum. Rerum rerum et sunt rerum maiores doloremque. Suscipit nesciunt et repellat provident. Dolores et quidem consequatur et. Ullam officiis quo totam perferendis sint.

Blanditiis est omnis quo corporis suscipit qui a facilis. Officia in mollitia voluptatem ipsa nam. Neque est et iste. Nesciunt vitae vitae dolor dolorem accusantium ut maiores.

Provident et est veritatis aut officiis quo ad. Assumenda quam alias assumenda praesentium et. Ab nostrum adipisci est architecto ab repudiandae tempora. Eos voluptatem qui fuga laudantium voluptates eos dolor sed. Officiis beatae non non perferendis eligendi exercitationem dolorum. Perferendis temporibus impedit fuga velit iusto voluptatibus sed. Aut sit possimus id sunt.

 

Non optio debitis nihil dignissimos odio. Consequuntur et accusamus tempora commodi expedita architecto qui. Quo et voluptates excepturi est non odit.

Exercitationem enim fugiat omnis libero ex. Sint omnis et laboriosam incidunt perferendis assumenda. Aperiam laudantium quibusdam fugiat inventore molestias. Accusantium illo et maxime ut.

Sunt placeat sunt facilis explicabo ut officiis nihil. Beatae odio harum minus quae molestias. Et quo recusandae distinctio.

A nobis est soluta ex saepe assumenda. Culpa doloribus enim magni.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.8%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 02 98.8%
  • Evercore 01 98.2%
  • BMO Capital Markets 12 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.8%
  • Morgan Stanley 05 98.3%
  • JPMorgan No 97.7%
  • BMO Capital Markets 12 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (44) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (78) $151
  • Intern/Summer Analyst (72) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
kanon's picture
kanon
99.0
5
Betsy Massar's picture
Betsy Massar
98.9
6
DrApeman's picture
DrApeman
98.9
7
dosk17's picture
dosk17
98.9
8
CompBanker's picture
CompBanker
98.9
9
GameTheory's picture
GameTheory
98.9
10
Mimbs's picture
Mimbs
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”